Reta Lila Weston Institute
Prof John Hardy
|
Professor John Hardy, PhD, FMedSci, FRS |
|
|
Prof John Hardy is a geneticist and molecular biologist
whose research interests
focus on neurological disease. Dr. Hardy received his B.Sc.
(Hons) degree
from the University of Leeds, UK (1976) and his Ph.D. from
Imperial College,
London, UK where he studied dopamine and amino acid
neuropharmacology.
Dr. Hardy received his postdoctoral training at the MRC
Neuropathogenesis
Unit in Newcastle upon Tyne, UK and then further postdoctoral
work at
the Swedish Brain Bank in Umeå, Sweden where he started to
work
on Alzheimer’s disease. He became Assistant Professor of
Biochemistry
at St. Mary’s Hospital, Imperial College, London in 1985 and
initiated
genetic studies of Alzheimer’s disease whilst there. He was
appointed
Associate Professor in 1989 and then took the Pfeiffer Endowed
Chair of
Alzheimer’s Research at the University of South Florida, in
Tampa
in 1992. In 1996 he moved to the Mayo Clinic in Jacksonville,
Florida,
as Consultant and Professor of Neuroscience. He became Chair
of Neuroscience
in 2000 and moved to NIA as Chief of the Laboratory of
Neurogenetics in
2001. He won the MetLife, the Allied Signal and the Potamkin
Prize for
his work in describing the first genetic mutations, in the
amyloid gene
in Alzheimer’s disease, in 1991. He was Head of the
Neurogenetics
Section, National Institute of Ageing, Bethesda, USA and in
2007 took up the Chair of Molecular Biology of Neurological Disease at
the UCL Institute of Neurology. In
recognition of his exceptional contributions to science, he was elected a
Fellow of the Royal
Society in 2009. In 2015, he was awarded the prestigious Breakthrough Prize. |
|
Address: 10-12 Russell Square House, Room 232 London, WC1B 5EH Tel: +44-20 3108 7466 Mobile: +44-77-6802 7039 Email: j.hardy[at]ucl.ac.uk PA: June Smalley (j.smalley [at] ucl.ac.uk) Phone: +44-20-3108 7467 |
Page last modified on 04 dec 15 14:01
